NeuroCog Trials, Inc., a Durham, N.C.-based cognitive services provider for the clinical trials industry, received a $1.4M grant.
The Direct to Phase II grant was awarded by the Small Business Innovation Research (SBIR) program of the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).
Led by Richard Keefe Ph.D., Founder and Chief Executive Officer, the company will use the funds for further validation of its iPad-based Brief Assessment of Cognition (BAC) app for use as a screening tool for cognitive decline in age-related CNS disorders.
The 2-year funded project builds on the company-sponsored development of the BAC App from the pen-and-paper version of the BAC that is widely-used in international clinical trials and academic studies.
The BAC App facilitates rater administration of the cognitive performance tests to patients with standardized voice-over task instructions, automated presentation of stimuli and features recording of responses, access to data, and the option for audio recording of test sessions for independent data quality review.
The grant project will incorporate new tests suited for screening individuals for cognitive decline, establish normative performance data in healthy controls aged 55+, and compare healthy controls and aging adults with cognitive complaints.